Morphea - Morfea
☆ Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Lezyon an nan Morfea (Morphea) anjeneral parèt kòm yon plak pigman atrofik.
References
Scleroderma se yon maladi ra ki afekte tisi konjonktif yo, ki parèt tankou po ki di e pafwa afekte lòt pati nan kò a. Gen de kalite prensipal yo: systemic sclerosis , ki enplike po redi ak ògàn entèn yo, ak localized scleroderma , ke yo rele tou morphea, ki tipikman rete limite a po a ak tisi anba li, ak yon kou benign ak pwòp tèt ou-limite. Malgre ke sklerodèrma lokalize pa komen ak kòz li yo pa klè, rechèch resan sijere li ka afekte ògàn entèn yo tou epi mennen nan divès pwoblèm sante. Tretman bonè enpòtan anpil pou anpeche konplikasyon, paske localized scleroderma yo ka grav.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea , ke yo rele tou sklerodèrma lokalize, se yon maladi otoiminitè ki ra ki afekte tisi konjonktif. Li ka parèt nan diferan fason, epi li pa trè komen, ak apeprè 0. 4 - 2. 7 ka pou chak 100,000 moun chak ane. Morphea yo souvan wè nan timoun ki gen ant 2 ak 14 ane, epi li gen tandans afekte tifi pi souvan pase ti gason.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea se yon maladi ki ra anpil. Akòz konpozisyon foto a, algorithm la ka fè erè li ak morfea (morphea) .